Bleeding, Clotting & Transfusions in COVID-19 Patients on ECMO
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This study tracks bleeding, clotting problems, and blood transfusion needs in ICU patients with COVID-19 who are on a special heart-lung machine called V-V ECMO. It helps doctors understand how to better care for these very ill patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed COVID-19 infection (PCR test positive).
- You must be receiving V-V ECMO (a type of heart-lung machine) at the hospital where this study is being done.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how blood clotting cells (platelets) behave when patients are on a heart-lung support machine called ECMO. Researchers will take small blood samples to understand if the machine affects platelet function and how to manage blood thinning medication safely.
This study looks at how well patients recover after needing a heart-lung bypass machine (VV-ECMO) during or right after emergency chest surgery. It aims to understand what affects their prognosis.
This study looks at how often blood clot–related problems happen in people hospitalized with serious COVID-19 lung illness. It may help doctors understand risks and improve care for patients in the hospital.
This trial tests whether a heart-lung machine called venovenous ECMO can help people with severe breathing failure get less sedated, get extubated (have the breathing tube removed), and start moving. It’s for certain adults who are on a ventilator for a short time and have specific oxygenation problems.
This trial studies whether people on a breathing machine called VV-ECMO can be managed without routine blood thinners, to reduce bleeding risk. It is meant for adults with severe lung failure (ARDS) and checks that it is safe for you to avoid anticoagulation.
This study looks at how well antibiotics and other anti-infective drugs work in very sick patients who are on a heart-lung machine called ECMO. If you're in the ICU with a serious infection, this trial could help doctors figure out the best dose for you.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.